AlloVir Inc Ordinary Shares (NASDAQ:ALVR)
North American company
Share Price Chart
- Chart currently unavailable -
Market Info - ALVR
- Market Open Price0.00
- Previous Close0.00
- Volume-
- 52w Low/High-
- Last Trade Price0.00
- Bid/Ask Price0.00
Company Info - ALVR
- Market Cap$2.789bn
- SymbolNASDAQ:ALVR
- IndustryHealthcare
- SectorBiotechnology
- Currency
- ISINUS0198181036
Company Profile
AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6.
Latest ALVR news
Currently there for this company. Visit our news hub for other news .